close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Medical History

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Medical History

Review your patient’s information.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Lindsey Roeker

location-icon

Rochester, MN

LOCATION OF PRACTICE
Roper St. Francis Mount Pleasant Hospital
MEDICAL Specialty:

Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma, Non-hodgkin's Lymphoma



200 1ST ST SW, ROCHESTER, MN, 559050001
200 1ST ST SW, ROCHESTER, MN, 559050001
507-284-2511
NPI Number
1497168538
ABOUT

Lindsey Roeker, MD, is a hematologist in Roseburg, OR. She frequently treats conditions such as Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, and Marginal Zone Lymphoma. Patients have rated her an average of 5.

Dr. Lindsey Roeker profile image

Published Articles

Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia.- 2026 Feb
Patient-reported outcomes among patients with mantle cell lymphoma or chronic lymphocytic leukemia receiving pirtobrutinib in the BRUIN phase 1/2 study: final analysis.- 2025 Dec
Can minimal residual disease be used to tailor therapy duration for chronic lymphocytic leukemia patients?- 2026 Apr
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience.- 2026 Jan 7
Chronic Enterovirus Meningitis with Acute Hepatitis in a Patient with Chronic Lymphocytic Leukemia Treated with Venetoclax/Obinutuzumab: A Case Report.- 2025 Jan-Dec
Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia.- 2026 Jan 1
Erratum: Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321).- 2025 Sep
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosis.- 2025 Sep
Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.- 2025 Sep
Erratum: Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321).- 2025 Aug 10

Clinical Trials

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

Other Specialists treating Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma, Non-Hodgkin's Lymphoma in Rochester, MN

See All Doctors

Dr. Saad Kenderian

Specialty: Chronic Lymphocytic Leukemia, Oral Cancer, Anemia

My Resources
My Resources

Dr. Grzegorz Nowakowski

Specialty: Diffuse Large B-Cell Lymphoma, Primary Central Nervous System Lymphoma, Non-Hodgkin's Lymphoma

My Resources
My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider